RARE icon

Ultragenyx Pharmaceutical
RARE

Overview Fund Activity

310 hedge funds and large institutions have $3.68B invested in Ultragenyx Pharmaceutical in 2024 Q4 according to their latest regulatory filings, with 55 funds opening new positions, 110 increasing their positions, 108 reducing their positions, and 42 closing their positions.

Holders
310
Holders Change
+12
Holders Change %
+4.03%
% of All Funds
4.13%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.07%
New
55
Increased
110
Reduced
108
Closed
42
Calls
$31.5M
Puts
$37.9M
Net Calls
-$6.41M
Net Calls Change
-$10.7M

Top Buyers

1
VPC
1
Vestal Point Capital
New York
$63.1M
2
BlackRock
2
BlackRock
New York
$275M
3
DTC
3
Deep Track Capital
Connecticut
$27.5M
4
Pictet Asset Management
4
Pictet Asset Management
Switzerland
$49.4M
5
Point72 Asset Management
5
Point72 Asset Management
Connecticut
$49.8M

Top Sellers

1
Wellington Management Group
1
Wellington Management Group
Massachusetts
$103M
2
Alkeon Capital Management
2
Alkeon Capital Management
New York
$71M
3
Sands Capital Management
3
Sands Capital Management
Virginia
$181M
4
AQR Capital Management
4
AQR Capital Management
Connecticut
$11.8M
5
T. Rowe Price Associates
5
T. Rowe Price Associates
Maryland
$106M
Name Market Value Shares Shares
Change 		Shares
Change %
MB
51
MPM BioImpact
Massachusetts
$16.5M 391,018 +61,285 +19%
Nuveen Asset Management
52
Nuveen Asset Management
Illinois
$16.4M 388,661 -4,099 -1%
Bank of America
53
Bank of America
North Carolina
$16.3M 388,502 -537,408 -58%
Schroder Investment Management Group
54
Schroder Investment Management Group
United Kingdom
$15.9M 376,161 +193,296 +106%
Hudson Bay Capital Management
55
Hudson Bay Capital Management
Connecticut
$15.9M 377,500 +182,500 +94%
APM
56
Avidity Partners Management
Texas
$14.8M 352,000 -400,000 -53%
DZ Bank
57
DZ Bank
Germany
$14.6M 346,597 +51,874 +18%
UBS Group
58
UBS Group
Switzerland
$13.7M 325,651 +232,582 +250%
EMFAT
59
Emerald Mutual Fund Advisers Trust
Pennsylvania
$13.6M 324,437 -104,865 -24%
Aberdeen Group
60
Aberdeen Group
United Kingdom
$13.3M 317,125 +63,821 +25%
Man Group
61
Man Group
United Kingdom
$12.5M 297,394 -29,809 -9%
Citadel Advisors
62
Citadel Advisors
Florida
$12M 286,179 +238,226 +497%
D.E. Shaw & Co
63
D.E. Shaw & Co
New York
$12M 286,079 +24,485 +9%
Verition Fund Management
64
Verition Fund Management
Connecticut
$12M 285,041 +207,735 +269%
Macquarie Group
65
Macquarie Group
Australia
$11.9M 282,963 +7,036 +3%
AQR Capital Management
66
AQR Capital Management
Connecticut
$11.8M 280,547 -763,826 -73%
Prudential Financial
67
Prudential Financial
New Jersey
$11.5M 272,940 +237,003 +659%
WP
68
Woodline Partners
California
$11.3M 269,556 +2,001 +0.7%
Fisher Asset Management
69
Fisher Asset Management
Washington
$11.2M 265,189 +265,189 New
PFM
70
Privium Fund Management
Netherlands
$10.9M 258,380 +15,868 +7%
Renaissance Technologies
71
Renaissance Technologies
New York
$10.7M 254,700 +72,600 +40%
MCM
72
Moore Capital Management
New York
$10.3M 245,000 – –
SFM
73
Sphera Funds Management
Israel
$9.62M 228,776 +33,427 +17%
Manulife (Manufacturers Life Insurance)
74
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$9.11M 216,587 -21,468 -9%
Barclays
75
Barclays
United Kingdom
$8.67M 206,108 +126,562 +159%
1 2
3
4 5